UnitedHealth Group (NYSE:UNH) Stock Unloaded Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 31st, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on May 15th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Zimmer Biomet (NYSE:ZBH) on 5/15/2025.
• Sold $15,001 – $50,000 in shares of Elevance Health (NYSE:ELV) on 5/15/2025.
• Sold $15,001 – $50,000 in shares of PepsiCo (NASDAQ:PEP) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of WEC Energy Group (NYSE:WEC) on 5/15/2025.
• Purchased $15,001 – $50,000 in shares of Advanced Micro Devices (NASDAQ:AMD) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Kraft Heinz (NASDAQ:KHC) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of Exxon Mobil (NYSE:XOM) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of Danaher (NYSE:DHR) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of International Flavors & Fragrances (NYSE:IFF) on 5/15/2025.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $304.27 on Tuesday. The business has a 50 day simple moving average of $426.60 and a 200-day simple moving average of $490.74. The stock has a market capitalization of $276.01 billion, a PE ratio of 19.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company posted $6.91 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Financial Management Professionals Inc. increased its holdings in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares during the last quarter. Western Pacific Wealth Management LP increased its holdings in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares during the last quarter. Richwood Investment Advisors LLC increased its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after purchasing an additional 20 shares during the last quarter. Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock worth $47,000 after purchasing an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC increased its holdings in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. HSBC restated a “reduce” rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Finally, Wolfe Research decreased their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $439.17.

Insider Activity

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by insiders.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.